CPMS | NEWSLETTER | ERN
HealthFlex
×
  • Home
  • The Network
    • Who We Are
    • Our Vision, Mission & Aim
    • Structure & Governance
    • Specialised Centres
    • Coordinators
    • Stakeholders & Supporters
    • Informative Materials
  • For Patients
    • Patient Board
    • Find a specialist centre
    • Patient Organisations
    • Patient Resources
    • Cross-border Healthcare
  • For Professionals
    • Education Programme
    • Evaluation
    • Guidelines
    • UIMD Registry
    • Subnetworks
    • Work Packages
    • Transversal Activities
    • CPMS Support
    • Resources
  • Activities
    • Projects
    • Publications
  • News & Events
    • News
    • Events
  • Education Programme
    • My Courses
    • Login
  • Contact Us

EVALUATING THE DIRECT AND INDIRECT COSTS OF FABRY DISEASE IN ITALY

EVALUATING THE DIRECT AND INDIRECT COSTS OF FABRY DISEASE IN ITALY
NewsNews for PatientsResources

The Italian Anderson-Fabry Association commissioned a survey by C.R.E.A. Sanità in 2018 to evaluate various socio-economic aspects affecting the families and patients living with Fabry disease, such as the quality of life, methods of treatment, support from the National Health Service, and the costs related to the treatment of the disease.

106 patients with a confirmed diagnosis of Anderson Fabry responded to the survey; based on the estimates of the prevalence of Fabry disease among the Italian population, this survey’s coverage rate is within the range of 6.6% – 15.1%. The results of the study led to the scientific publication Survey about the Quality of Life of Italian Patients with Fabry Disease published in the open-access journal Diseases on October 2021.

The objective of this study was to calculate the direct and indirect costs borne by the Italian National Health System and the patients. Overall, the findings of the study highlight a good coverage of the National Health System for people with Fabry disease, other issues related to costs of assistance benefits and the indirect costs of managing the illness borne by the patient and family members.

Click here to read the full report.

Search

Last News & Events

  • Questionnaire on the Treatment of Primary Mitochondrial Disorders with Vitamins and Cofactors
  • Positive Results for MetabERN and ASUFC in the Five-Year Evaluation Process of European Reference Networks (ERN)
  • 20th Annual WORLDSymposium – February 4-9, 2024
  • DCTEP Learners’ Stories:  What does an educational programme on IMDs have to offer to young healthcare professionals?
  • Call on the EU institutions and EU Member States’ governments to stand by the European Reference Networks
  • MOOC From Lab to Clinic: Translational Research for Rare Diseases
  • DCTEP learners’ stories: How does an e-learning on IMDs really look like?
  • Conference on Rare diseases and European reference networks in Bilbao

Activities

  • Publications and Guidelines
  • Unified Registry for Inherited Metabolic Disorders
  • Projects

Disclaimer

MetabERN is a European Reference Network (ERN) approved by the ERN Board of Member States.
The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
The content on this website represents the views of the network and is its sole responsibility; it can in no way be taken to reflect the views of the European Commission or any other body of the European Union.

For more information please contact
Prof. Maurizio Scarpa, MD, PhD
MetabERN Coordinator

Newsletter

Sign up to the MetabERN newsletter

Search the website


Copyright ©2017-2021 all rights reserved
Previous Content

Web by EFFIGE 2.0
To provide the best possible service, we use technical, statistical and third-party cookies on this site. Continuing the navigation you consent to use them. Accept Reject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT